{"id":947,"date":"2026-03-04T10:31:31","date_gmt":"2026-03-04T10:31:31","guid":{"rendered":"https:\/\/cansaran.com\/?p=947"},"modified":"2026-10-13T20:08:19","modified_gmt":"2026-10-13T20:08:19","slug":"effects-of-maternal-diabetes-on-the-fetal-heart","status":"publish","type":"post","link":"https:\/\/cansaran.com\/en\/effects-of-maternal-diabetes-on-the-fetal-heart\/","title":{"rendered":"Maternal Diabetes and Fetal Heart Health: Risks and Congenital Heart Defects"},"content":{"rendered":"<p>Maternal diabetes can directly affect fetal heart development, leading to structural and functional cardiac anomalies. Especially uncontrolled hyperglycemia during the first trimester of pregnancy increases the risk of congenital heart defects. This condition is associated with septal defects, cardiomyopathy, and great vessel anomalies.<\/p>\n<p>Uncontrolled maternal diabetes during pregnancy may predispose the fetus to the development of hypertrophic cardiomyopathy. Increased fetal insulin levels cause thickening in the myocardial tissue. This condition becomes particularly evident in the interventricular septum and may result in temporary or permanent cardiac dysfunction in the postnatal period.<\/p>\n<p>Lack of preconceptional glycemic control significantly increases the risk of cardiac malformations during the period when organs develop. High HbA1c levels have been associated with severe congenital heart diseases such as outflow tract anomalies and transposition. Achieving early metabolic balance has a protective effect.<\/p>\n<p>Early diagnosis of diabetes-related cardiac changes is possible with fetal echocardiography. Detailed examination especially performed between the 18th and 22nd weeks of pregnancy enables the detection of structural defects and myocardial thickening. Regular obstetric follow-up and metabolic control are critically important in reducing perinatal morbidity.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_89 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #ffffff;color:#ffffff\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #ffffff;color:#ffffff\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/cansaran.com\/en\/effects-of-maternal-diabetes-on-the-fetal-heart\/#Fetal_Heart_Development_and_Critical_Periods\" >Fetal Heart Development and Critical Periods<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/cansaran.com\/en\/effects-of-maternal-diabetes-on-the-fetal-heart\/#Association_with_Congenital_Heart_Diseases\" >Association with Congenital Heart Diseases<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/cansaran.com\/en\/effects-of-maternal-diabetes-on-the-fetal-heart\/#Diabetic_Fetopathy_and_Cardiac_Hypertrophy\" >Diabetic Fetopathy and Cardiac Hypertrophy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/cansaran.com\/en\/effects-of-maternal-diabetes-on-the-fetal-heart\/#Changes_in_Fetal_Cardiac_Functions\" >Changes in Fetal Cardiac Functions<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/cansaran.com\/en\/effects-of-maternal-diabetes-on-the-fetal-heart\/#Diagnostic_Evaluation_Process\" >Diagnostic Evaluation Process<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/cansaran.com\/en\/effects-of-maternal-diabetes-on-the-fetal-heart\/#Risk_Factors_and_Preventive_Approach\" >Risk Factors and Preventive Approach<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/cansaran.com\/en\/effects-of-maternal-diabetes-on-the-fetal-heart\/#In_Which_Situations_Is_Specialist_Evaluation_Necessary\" >In Which Situations Is Specialist Evaluation Necessary?<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Fetal_Heart_Development_and_Critical_Periods\"><\/span>Fetal Heart Development and Critical Periods<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The fetal heart develops between the 3rd and 8th weeks of pregnancy. This period is called \u201corganogenesis\u201d (organ development) and includes complex processes such as looping of the embryonic heart tube, septation (separation of chambers), and development of the great vessels. At the cellular level; neural crest cells, mesodermal tissues, and various growth factors regulate this development.<\/p>\n<p>Maternal hyperglycemia may cause increased oxidative stress, free radical formation, and disruption in cellular signaling pathways during this critical period. These biochemical changes may affect the process of cardiac morphogenesis (structural formation of the heart), increasing the risk of congenital heart anomalies. However, this does not mean that every pregnant woman with diabetes will develop a fetal heart anomaly; the risk is associated with the individual level of metabolic control.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Association_with_Congenital_Heart_Diseases\"><\/span>Association with Congenital Heart Diseases<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Maternal diabetes is a known risk factor for congenital heart diseases. The most commonly reported anomalies include:<\/p>\n<ul>\n<li aria-level=\"1\">Ventricular septal defect (VSD)<\/li>\n<li aria-level=\"1\">Atrial septal defect (ASD)<\/li>\n<li aria-level=\"1\">Transposition of the great arteries<\/li>\n<li aria-level=\"1\">Tetralogy of Fallot<\/li>\n<li aria-level=\"1\">Truncus arteriosus<\/li>\n<\/ul>\n<p>These structural disorders may present as incomplete closure of the walls between the heart chambers or abnormalities in the positioning of the great vessels. The risk is particularly more pronounced in women with pregestational diabetes and inadequate blood glucose control during early pregnancy.<\/p>\n<p>Since gestational diabetes usually develops during the second half of pregnancy, its association with structural heart anomalies is lower compared to pregestational diabetes. Nevertheless, it may still affect fetal cardiac function.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Diabetic_Fetopathy_and_Cardiac_Hypertrophy\"><\/span>Diabetic Fetopathy and Cardiac Hypertrophy<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>One of the most common functional effects of maternal diabetes on the fetal heart is hypertrophic cardiomyopathy. This condition is characterized especially by thickening of the interventricular septum (the wall separating the heart chambers).<\/p>\n<p>In response to hyperglycemia, hyperinsulinemia develops in the fetus. Increased insulin production by the fetal pancreas may lead to hypertrophy of the heart muscle due to the anabolic (growth-promoting) effect of insulin. This condition is considered part of \u201cdiabetic fetopathy.\u201d<\/p>\n<p>In most cases, this thickening may regress during the postnatal period. However, some newborns may experience temporary respiratory distress, difficulty with circulatory adaptation, or transient impairment in cardiac functions. Therefore, clinical follow-up is important.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Changes_in_Fetal_Cardiac_Functions\"><\/span>Changes in Fetal Cardiac Functions<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Apart from structural anomalies, maternal diabetes may cause subclinical changes in the fetus such as diastolic dysfunction (problems during the relaxation phase of the heart). Evaluations performed with fetal echocardiography may reveal changes in ventricular filling parameters in some cases.<\/p>\n<p>These changes are generally asymptomatic and may improve after birth. However, maintaining metabolic control throughout pregnancy contributes to keeping these functional effects at a minimal level.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Diagnostic_Evaluation_Process\"><\/span>Diagnostic Evaluation Process<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Pregnancy follow-up in the presence of maternal diabetes requires a multidisciplinary approach. The obstetrician and gynecologist, endocrinologist, and when necessary, pediatric cardiologist work in collaboration.<\/p>\n<p>During the diagnostic process:<\/p>\n<ul>\n<li aria-level=\"1\">Detailed ultrasonography<\/li>\n<li aria-level=\"1\">Fetal echocardiography<\/li>\n<li aria-level=\"1\">Monitoring maternal HbA1c levels<\/li>\n<li aria-level=\"1\">Oral glucose tolerance test (when necessary)<\/li>\n<\/ul>\n<p>such evaluations may be performed.<\/p>\n<p>Fetal echocardiography is generally recommended between the 18th and 24th weeks of pregnancy. This examination allows detailed evaluation of the anatomical structure and functions of the heart. However, the decision regarding which examination is necessary for which pregnant woman is made according to individual risk factors.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Risk_Factors_and_Preventive_Approach\"><\/span>Risk Factors and Preventive Approach<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The effects of maternal diabetes on the fetal heart are mostly associated with the level of metabolic control. Especially high pre-pregnancy HbA1c levels may increase the risk of congenital anomalies. Therefore, preconceptional counseling is important for patients with diabetes planning pregnancy.<\/p>\n<p>The main components of the preventive approach are:<\/p>\n<ul>\n<li aria-level=\"1\">Optimal glycemic control before pregnancy<\/li>\n<li aria-level=\"1\">Regular blood glucose monitoring<\/li>\n<li aria-level=\"1\">Balanced nutrition and medical nutrition therapy<\/li>\n<li aria-level=\"1\">Adjustment of insulin therapy when necessary<\/li>\n<li aria-level=\"1\">Close obstetric follow-up<\/li>\n<\/ul>\n<p>These measures do not guarantee complete elimination of the risk; however, they may help reduce the likelihood of complications.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"In_Which_Situations_Is_Specialist_Evaluation_Necessary\"><\/span>In Which Situations Is Specialist Evaluation Necessary?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Further evaluation may be required in the following situations:<\/p>\n<ul>\n<li aria-level=\"1\">History of pregestational diabetes<\/li>\n<li aria-level=\"1\">High HbA1c levels<\/li>\n<li aria-level=\"1\">History of congenital heart anomalies in a previous pregnancy<\/li>\n<li aria-level=\"1\">Suspicious cardiac findings on ultrasonography<\/li>\n<\/ul>\n<p>In these situations, perinatology and pediatric cardiology evaluation may be planned. Every clinical decision is made by evaluating the mother\u2019s metabolic condition, gestational week, and fetal findings together.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Maternal diabetes can directly affect fetal heart development, leading to structural and functional cardiac anomalies. Especially uncontrolled hyperglycemia during the first trimester of pregnancy increases the risk of congenital heart defects. This condition is associated with septal defects, cardiomyopathy, and great vessel anomalies. Uncontrolled maternal diabetes during pregnancy may predispose the fetus to the development [&#8230;]\n","protected":false},"author":1,"featured_media":943,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[23],"tags":[],"class_list":["post-947","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general"],"_links":{"self":[{"href":"https:\/\/cansaran.com\/en\/wp-json\/wp\/v2\/posts\/947","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cansaran.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cansaran.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cansaran.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cansaran.com\/en\/wp-json\/wp\/v2\/comments?post=947"}],"version-history":[{"count":3,"href":"https:\/\/cansaran.com\/en\/wp-json\/wp\/v2\/posts\/947\/revisions"}],"predecessor-version":[{"id":3074,"href":"https:\/\/cansaran.com\/en\/wp-json\/wp\/v2\/posts\/947\/revisions\/3074"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cansaran.com\/en\/wp-json\/wp\/v2\/media\/943"}],"wp:attachment":[{"href":"https:\/\/cansaran.com\/en\/wp-json\/wp\/v2\/media?parent=947"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cansaran.com\/en\/wp-json\/wp\/v2\/categories?post=947"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cansaran.com\/en\/wp-json\/wp\/v2\/tags?post=947"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}